Article List

WPRIM Management System> DCMS> Kidney Research and Clinical Practice> > 31> 3

1. Association between vascular access failure and microparticles in hemodialysis patients.	Page:200—201
2. Renal infarction caused by paradoxical embolism through a patent foramen ovale.	Page:196—199
3. Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney disease.	Page:192—195
4. Hyperuricemia as a marker for progression of immunoglobulin A nephropathy.	Page:186—191
5. Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway.	Page:177—185
6. Clinical characteristics of acute renal failure with severe loin pain and patchy renal vasoconstriction.	Page:170—176
7. Use of low-dose sulodexide in IgA nephropathy patients on renin-angiotensin system blockades.	Page:163—169
8. Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants.	Page:157—162
9. Impact of initial blood flow on outcomes of vascular access in hemodialysis patients.	Page:151—156
10. Epigenetic modifications and diabetic nephropathy.	Page:139—150
11. Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside.	Page:132—138
12. Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease?.	Page:129—131